JAK2 Test Kit Market – Qiagen, Others, Compete: White Paper
Loading...
The U.S. Food and Drug Administration (FDA) recently cleared Qiagen’s ipsogen JAK2 RGQ PCR Kit for detection of the V617F mutation on the JAK2 gene associated with the myeloproliferative disorder polycythemia vera. This white paper examines the market for these products and the competition.
- About JAK2
- Qiagen Test Approval
- Market
In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.
Most Popular Research
- Walk-in Store Clinics (Retail Clinics) Bring Healthcare to Consumers, While Other Venues Wait for Patients
- China's 3.2 Billion-Dollar In Vitro Diagnostics Market: Opportunity for Surplus Growth
- The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition
- No Easy Road for POC Molecular Diagnostics in Developing World: White Paper
- The Global Market for Medical Devices, 8th Edition (40+ Specific Device Markets and 23 Country Markets Forecasted to 2022)
- The Market Share Picture in the Point-of-Care Diagnostics Market